Posts Categorized: Biotechnology

Creative Biolabs: Leap Beyond Conventional Membrane Protein Discovery

Posted filed under Biotechnology.

Membrane proteins are valuable assets to drug discovery as their functions are involved in extensive biological processes in the human body, such as ligand-receptor binding, signal transduction, transportation of molecules, and intracellular recognition. Creative Biolabs is a conscientious contract research organization working in biotechnology areas with a particular emphasis on protein discovery, which helps design… Read more »

Creative Biolabs Sets Sights on Single-Domain Antibodies’ Protection Against COVID-19

Posted filed under Biotechnology.

The findings recently published in Cell Reports described that immune particles derived from llamas’ blood have the potential to provide protection against Omicron, SARS-CoV-2, and other 18 COVID-19 variants. Scientists at Creative Biolabs nod at this study as special VHH antibodies (or single-domain antibodies, sdAbs) produced by llamas, camels, and alpacas only have a single… Read more »

MedC Biopharma Partners with A2W Pharma to develop Cannabinoid Therapeutics

Posted filed under Biotechnology.

MedC Biopharma today announced a partnership with A2W Pharma of Malta in the development of MedC’s proprietary novel cannabinoid formulations for the treatment of various cancer-related indications. A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company. MedC Biopharm is focused on cannabinoid… Read more »

Artemis DNA to Wind-Down Texas Operations and Shift Focus to Expand Oncology Portfolio in California

Posted filed under Biotechnology.

Artemis DNA, Inc. (“Artemis DNA” or the “company”), a leading global diagnostic laboratory company, announced today that they have made the difficult decision to close their Houston, Texas facility. “This was certainly one of the most difficult decision I have had to make with Artemis DNA,” commented Ms. Emylee Thai, Founder of Artemis DNA. “As our first… Read more »

Artemis DNA Forays Into Multi-Billion Dollar Cancer Liquid Biopsy Market

Posted filed under Biotechnology.

Artemis DNA, Inc. (“Artemis DNA” or the “company”), a leading USA-based diagnostic laboratory company, announced today that they will be offering revolutionary new cancer liquid biopsy tests through an exclusive partnership with Datar Cancer Genetics (Datar).  The agreement, a $250 million contract, grants Artemis DNA the exclusivity to be the only company that will commercialize and… Read more »